{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:32:24Z","timestamp":1777329144010,"version":"3.51.4"},"publisher-location":"Totowa, NJ","reference-count":18,"publisher":"Humana Press","isbn-type":[{"value":"9781617795350","type":"print"},{"value":"9781617795367","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-61779-536-7_30","type":"book-chapter","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T21:39:07Z","timestamp":1330119547000},"page":"355-364","source":"Crossref","is-referenced-by-count":22,"title":["A 6-Hydroxydopamine In Vivo Model of Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Giulia","family":"Mercanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Bazzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"30_CR1_30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, and Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"30_CR2_30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nbd.2007.11.002","volume":"30","author":"A Recchia","year":"2008","unstructured":"Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD and Giusti P (2008) Generation of alpha-synuclein-based rat model of Parkinson\u2019s disease. Neurobiol Dis 30:8\u201318","journal-title":"Neurobiol Dis"},{"key":"30_CR3_30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1126\/science.290.5492.767","volume":"290","author":"JH Kordower","year":"2000","unstructured":"Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al (2000) Neurode-generation prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease. Science 290:767\u201373","journal-title":"Science"},{"key":"30_CR4_30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/380252a0","volume":"380","author":"DM Gash","year":"1996","unstructured":"Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L et al (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252\u2013255","journal-title":"Nature"},{"key":"30_CR5_30","doi-asserted-by":"publisher","unstructured":"Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, Morgan WW et al (2010) Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson\u2019s disease. Mol Ther; doi:\n                  10.1038\/mt.2010.107","DOI":"10.1038\/mt.2010.107"},{"key":"30_CR6_30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1586\/ern.10.55","volume":"10","author":"T Yasuda","year":"2010","unstructured":"Yasuda T and Mochizuki H (2010) Use of growth factors for the treatment of Parkinson\u2019s disease. Expert Rev Neurother 10:915\u2013924","journal-title":"Expert Rev Neurother"},{"key":"30_CR7_30","doi-asserted-by":"publisher","first-page":"16469","DOI":"10.1523\/JNEUROSCI.2440-10.2010","volume":"30","author":"J Laganiere","year":"2010","unstructured":"Laganiere J, Kells AP, Lai JT, Guschin D, Paschon DE, Meng X et al (2010) An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson\u2019s disease. J Neurosci 30:16469\u201316474","journal-title":"J Neurosci"},{"key":"30_CR8_30","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/0024-3205(89)90365-2","volume":"44","author":"CE Lambert","year":"1989","unstructured":"Lambert CE, and Bondy SC (1989) Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress. Life Sci 44:1277\u20131284","journal-title":"Life Sci"},{"key":"30_CR9_30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","volume":"50","author":"Y Glinka","year":"1997","unstructured":"Glinka Y, Gassen M, and Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50:55\u201366","journal-title":"J Neural Transm Suppl"},{"key":"30_CR10_30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini A, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neuro-chem 76:1265\u20131274","journal-title":"J Neurochem"},{"key":"30_CR11_30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0166-2236(93)90070-3","volume":"16","author":"CW Olanow","year":"1993","unstructured":"Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439\u2013444","journal-title":"Trends Neurosci"},{"issue":"Suppl 2","key":"30_CR12_30","first-page":"S16","volume":"64","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Functional models of Parkinson\u2019s disease: a valuable tool in the development of novel therapies. Ann Neurol 64(Suppl 2):S16\u2013S29","journal-title":"Ann Neurol"},{"key":"30_CR13_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopaminergic system. Acta Physiol Scand Suppl 367:95\u2013122","journal-title":"Acta Physiol Scand Suppl"},{"key":"30_CR14_30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107\u2013110","journal-title":"Eur J Pharmacol"},{"key":"30_CR15_30","unstructured":"Paxinos G, Watson C (1986) Rat Brain in Stereotaxic Coordinates San Diego, Academic Press"},{"key":"30_CR16_30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Bj\u00f6rklund A and Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303\u2013317","journal-title":"Exp Neurol"},{"key":"30_CR17_30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","volume":"72","author":"CS Lee","year":"1996","unstructured":"Lee CS, Sauer H and Bjorklund A (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat, Neuroscience 72:641\u2013653","journal-title":"Neuroscience"},{"key":"30_CR18_30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","volume":"84","author":"KM Sindhu","year":"2006","unstructured":"Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM et al (2006) Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84:321\u2013329","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Methods in Molecular Biology","Neurotrophic Factors"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-536-7_30.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T21:43:02Z","timestamp":1619905382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-61779-536-7_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781617795350","9781617795367"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-536-7_30","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}